The biomarker, called 'brain-derived tau,' or BD-tau, outperforms current blood diagnostic tests used to detect Alzheimer's-related neurodegeneration clinically. It is specific to Alzheimer's disease and correlates well with Alzheimer's neurodegeneration biomarkers in the cerebrospinal fluid. Scientists hope that monitoring blood levels of BD-tau could facilitate screening and enrollment of patients from populations that historically haven't been included in research cohorts.
from Healthy Aging News -- ScienceDaily https://ift.tt/4dhZ5sO
No comments:
Post a Comment